Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Apollomics Inc
Scientific Title
A Phase 1 Multicenter, Dose Escalation Study of CBT-501 in Subjects With Select Advanced or Relapsed/Recurrent Solid Tumors